Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IH
#2573
iHuman Inc. American depositary shares, each representing five Class A ordinary shares
1.7
3
-2.26%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-2.26%
Monatliche Änderung
-5.46%
6 month change
-38.43%
Jahresänderung
-9.90%
Vorheriger Schlusskurs
1.7
7
Open
1.7
3
Bid
Ask
Low
1.7
3
High
1.7
3
Volumen
1
Märkte
Aktien
Konjunkturunabhängige Konsumgüter
IH
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
116.08 M
481.36 M
Valuation ratios
Enterprise value
1.16 B
6.72 B
Price to earnings ratio
6.76
-117.61
Price to sales ratio
—
—
Price to cash flow ratio
57.14
242.31
Price to book ratio
3.48
23.85
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
-0.02
-0.08
Return on equity %
-0.02
-0.13
Return on invested capital %
-17.89
-82.59
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
2.93
9.96
Current ratio
2.98
10.14
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
-0.01
-0.04
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
0.59
2.28
Net current asset value per share
0.67
2.66
Tangible book value per share
0.49
1.77
Working capital per share
0.45
1.59
Book value per share
0.49
1.75
Nachrichten
iHuman: Undervalued With Geographical Expansion Upside (NYSE:IH)
iHuman reporta mayor beneficio en Q2 pese a caída en ingresos
iHuman reporta mayor beneficio en el segundo trimestre pese a caída en ingresos
iHuman reports higher Q2 profit despite revenue decline
iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results